Netarsudil dihydrochloride
CAS No. 1253952-02-1
Netarsudil dihydrochloride ( AR-13324 )
产品货号. M11023 CAS No. 1253952-02-1
Netarsudil (AR-13324) 是一种有效的选择性 ROCK 抑制剂,对 ROCK2 的 Ki 值为 4.2 nM。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥2025 | 有现货 |
|
| 10MG | ¥3588 | 有现货 |
|
| 25MG | ¥5929 | 有现货 |
|
| 50MG | ¥7995 | 有现货 |
|
| 100MG | ¥11259 | 有现货 |
|
| 200MG | 获取报价 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Netarsudil dihydrochloride
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Netarsudil (AR-13324) 是一种有效的选择性 ROCK 抑制剂,对 ROCK2 的 Ki 值为 4.2 nM。
-
产品描述Netarsudil (AR-13324) is a potent, selective ROCK inhibitor with Ki of 4.2 nM for ROCK2; 11 kinases are inhibited >90% in a panel of 422 kinases, only ROCK1 and ROCK2 (each 93% inhibition) and PKC (delta, 91%, and eta, 93% inhibition); exhibts improved bioavailability, demonstrates an effective and sustained IOP reduction for 24h after dosing; a novel ocular hypotensive agent for the treatment of Gglaucoma.Other Indication Approved.
-
体外实验——
-
体内实验Netarsudil hydrochloride (0.04%, 50 ΜL)reduces intraocular pressure (IOP) in normotensive monkey eyes.Netarsudil hydrochloride (0.04%) produces statistically significant lowering of episcleral venous pressure (EVP) in Dutch Belted rabbits. Animal Model:Adult female cynomolgus monkeys (3-5 kg)Dosage:0.04%, 50 μLAdministration:Topically applied to eye Result:Reduces IOP in normotensive monkey eyes.
-
同义词AR-13324
-
通路Cell Cycle/DNA Damage
-
靶点ROCK
-
受体ROCK
-
研究领域Other Indications
-
适应症Other Disease
化学信息
-
CAS Number1253952-02-1
-
分子量526.45
-
分子式C28H29Cl2N3O3
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : 5 mg/mL (9.50 mM)
-
SMILESCC1=CC(=C(C=C1)C(=O)OCC2=CC=C(C=C2)C(CN)C(=O)NC3=CC4=C(C=C3)C=NC=C4)C.Cl.Cl
-
化学全称(S)-4-(3-amino-1-(isoquinolin-6-ylamino)-1-oxopropan-2-yl)benzyl 2,4-dimethylbenzoate dihydrochloride
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Sturdivant JM, et al. Bioorg Med Chem Lett. 2016 May 15;26(10):2475-80.
2. Li G, et al. Eur J Pharmacol. 2016 Sep 15;787:20-31.
3. Lin CW, et al. J Ocul Pharmacol Ther. 2017 Jun 13. doi: 10.1089/jop.2017.0023.
021-51111890
购物车()
sales@molnova.cn

